Here's why the ResApp (ASX:RAP) share price is skyrocketing 60% today

More than 2 years after the WHO declared a pandemic, COVID-19 remains a prevalent virus.

| More on:
rising medical asx share price represented by excited doctors dancing in ward

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ResApp share price rockets 60% 
  • Initial smartphone based COVID-19 detection results surpass RAT tests 
  • Company to pursue regulatory approval and seek international partner 

The ResApp Health Ltd (ASX: RAP) share price is shooting the lights out today.

ResApp shares closed yesterday at 6.2 cents and are currently trading for 9.9 cents. That's a whopping 59.7% gain for the ResApp share price in early morning trade.

The ASX healthcare share is focused on developing smartphone applications to diagnose and manage respiratory diseases.

Shares went into a trading halt on Thursday and emerged from that pause today after the release of results from its smartphone-based COVID-19 screening test.

What COVID-19 screening results were announced?

Investors are bidding up the ResApp share price after the company reported positive results from its cough audio-based COVID-19 screening test.

The test uses only a regular smartphone and makes use of machine learning to analyse the sound of a patient's cough.

ResApp said the clinical trial – which recruited 741 patients of who 446 were COVID-19 positive – correctly detected the virus in 92% of infected participants. That success rate, according to the release, exceeds the real-world measured sensitivity of rapid antigen tests.

The company said it sees the best early market opportunities in settings where frequent testing is required. In these settings its smartphone test could cut back on the number of RAT or PCR tests being administered, which would reduce costs and offer a more readily available test.

The ResApp share price could be getting an additional lift today from management's plans to now seek approvals from regulators and accelerate commercialisation of the smartphone test by partnering with a global health or technology company.

Commenting on the positive results, ResApp CEO, Tony Keating said:

The WHO have recently warned that the pandemic is not over, that health systems globally continue to strain under the current caseload and that we should be prepared for the potential of more dangerous variants to emerge.

We intend to accelerate commercialisation by immediately engaging with regulators globally and we have already commenced discussions with global health and technology companies with the goal of rapidly bringing this product to market.

Catherine Bennett, chair of epidemiology at Deakin University added, "The simplicity, ease of use and unlimited scalability of ResApp's test will be welcomed by public health officials around the world."

ResApp share price snapshot

With today's momentous intraday charge higher factored in, the ResApp share price is up 38.5% in 2022.

That compares to a year-to-date loss of 3.6% posted by the All Ordinaries Index (ASX: XAO).

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough start to the week this Monday.

Read more »

Crude oil barrels rocketing.
ETFs

Why did the BetaShares Crude Oil ETF just spike 4%?

This ETF is attracting buyers in today's seller's market.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why BWP, Metcash, Resolute Mining, and SHAPE shares are pushing higher today

These shares are starting the week on a positive note. But why?

Read more »

Workers at the port joyfully jump high in the air with shipping containers in the background.
Industrials Shares

$10,000 invested in Austal shares a year ago is now worth…

Austal is an Australian shipbuilding company founded in 1988 that builds ships for the US Navy.

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing end to a disappointing week for investors this Friday.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Betr, Centuria Capital, GR Engineering, and Mach7 shares are pushing higher

These shares are having a good finish to the week. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX gave up an afternoon lead to close lower today.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Clarity Pharmaceuticals, Kelsian, Life360, and Syrah shares are rising today

These shares are pushing higher on Thursday. But why?

Read more »